NIDA supports epidemiology, policy analysis and general public well being results investigation associated with cannabis use, such as the Checking the longer term study in addition to a medicinal cannabis use registry.In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they intend to reclassify cannabis for a Agenda III drug. This res